Neurobiological Technologies, Inc. (Nasdaq: NTII)
2000 Powell Street, Suite 800Emeryville, CA 94608
Tel. (510) 595-6000
Fax (510) 595-6006
www.ntii.com
State of Incorporation: Delaware
Fiscal Year End: June 30
Executive Team:
- Paul E. Freiman, President and Chief Executive Officer
- Lisa U. Carr, M.D., Ph.D., Senior Vice President, Chief Medical Officer
- David E. Levy, M.D., Vice President of Clinical Development
- Karl G. Trass, Vice President, Regulatory Affairs & Quality Assurance
Board of Directors:
- Abraham E. Cohen, Chairman
- Paul E. Freiman
- Enoch Callaway, M.D.
- Ronald E. Cape, Ph.D.
- Theodore L. Eliot, Jr.
- F. Van Kasper
- Abraham D. Sofaer
- John B. Stuppin
Audit Committee:
- F. Van Kasper, Chairman
- Theodore L. Eliot, Jr.
- Abraham D. Sofaer
Compensation Committee
- Abraham D. Sofaer, Chairman
- Ronald E. Cape, Ph.D.
- Theodore L. Eliot, Jr.
Nominating and Corporate Governance Committee:
- Ronald E. Cape, Ph.D., Chairman
- Enoch Callaway, M.D.
- Abraham D. Sofaer